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standardized infusion times. A symptom assessment survey
was completed by patients for comparing gravity infusions
with infusions via the IV pump. Nurses were survey
regarding this change in practice.
Evaluation: Patient symptoms were rated for cryopreserved
cell infusion prior to and after the initiation of a standardized
infusion time of 10 minutes. Nurses were asked to rate the
efﬁciency of utilizing an IV pump compared to gravity infu-
sion. Patients who entered the program with a previous
placed catheter that was not a 12F CVC were tracked to
determine a potential cost beneﬁt.
Discussion: By utilizing standardized infusion times and an
IV pump both nurses and patients have a better experience
with cell infusions.516
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One of the most rewarding parts of caring for the blood
and marrow transplant (BMT) patient is the long term rela-
tionships we build with them. Patients are often hospitalized
for extended periods of time and with the primary nursing
model, nurses have the opportunity to really get to know
their patients. For all of the rewards and beneﬁts this brings,
it also has inherent risks. The risk of drift from standards of
practice is notable due to our comfort level and familiarity
with patients and protocols. In addition, blood and marrow
transplant patients typically receive common medication
regimens, including antibiotics and immunosuppressive
agents. One look at the medication area for a BMT unit
reveals that most patients are receiving similar, if not the
same medications.
The journey towards a ‘Just Culture’ in our hospital has
successfully encouraged the use of the Self-Reporting
System when a medication error or near miss occurs, and
the BMT unit has consistently been recognized as a high-
reporting unit. The Oncology Safety Oversight Committee
conducted a three year retrospective analysis for speciﬁc
medication errors and an increase in the number of medi-
cation errors related to patient identiﬁcation was noted. The
BMT unit accounted for a total of 15 events reported, which
was 48% of all the errors of this type reported in Oncology. A
review of the literature suggested a link of this type of error
to ‘conﬁrmation bias’ which is when we see what is ex-
pected rather than what is there. A Failure Mode and Effect
Analysis was performed and the opportunity for conﬁrma-
tion bias was identiﬁed. Changes to a process such as
medication administration that disrupts the typical ﬂow
and thought process can reduce the tendency for the
conﬁrmation bias factor and the related potential errors. A
60 day trial was conducted where the fourth character of
the patient's medical record number on the IV bag label had
to be struck through by the nurse as part of the medication
administration “6 Rights.” This would potentially disrupt
the tendency to look at the number for conﬁrmation of the
expected medical record number. Staff feedback and
ongoing error rates were recorded to assess the effective-
ness of the trial.
As with many practice changes, unit leadership found
the need to reinforce communication of the practice changeand perform ongoing audits to ensure compliance. During
the 60 day trial, no patient identiﬁcation errors were re-
ported. Staff, given the choice, voted to incorporate the
practice into the unit's standard procedure for medication
administration. Since initiation of the strike through
process 18 months ago; only one event has been reported
and the practice has become part of the unit culture. The
practice has also been benchmarked by other units in the
hospital.517
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Purpose and Background: According to published guide-
lines from FACT, apheresis must be performed by “adequately
trained” collection personnel. This recommendation gives
collection facilities wide latitude to determine the appro-
priate skill set for optimal apheresis collections. Comparing
apheresis-trained oncology nurses with apheresis techni-
cians, our program determined which group was best suited
for the early recognition and treatment of procedure-related
adverse reactions based on patient outcomes.
Upon the initiation of our community-based blood and
marrow transplant (BMT) program in 2007, the collection of
hematopoietic progenitor cells was contracted to a local
blood center. There were 35 collections performed on 12
patients using the contracted apheresis technicians on site.
Seventy-ﬁve percent (75%) of patients experienced apheresis
complications requiring immediate medical attention.
Interventions: To improve the quality outcomes within our
BMT program, a comprehensive nursing education plan was
developed and implemented in November 2008. A core
group of oncology nurses completed a competency-based
apheresis program. Protocols were developed for the nurse
to manage pre-emptive medical interventions when
required. Subsequent to this intervention, we used these
nursing personnel exclusively for collections.
Outcome: As of 2011, there have been 96 collections on 40
patients since switching to apheresis-trained nursing
personnel. With this change only 7.5% of the patients expe-
rienced adverse reactions, a ten-fold decrease. Although not
quantiﬁed, program staff felt there was additional improve-
ment to the quality of patient care; as therewas a decrease in
delays to addressing adverse reactions. The shift from tech-
nicians to apheresis trained oncology nurses was a timely
nursing intervention which improved patient outcomes by
an order of magnitude.518
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